Table: Kissei Pharm -Q1 group results

Kissei Pharmaceutical

29/07/2025 07:30

Jul 29 (Reuters)- 
             Kissei Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             22.19               21.16            91.50    
                 (+4.9 pct)          (+9.6 pct)       (+3.6 pct)  
  Operating          2.11                2.16          loss 4.00  
                 (-2.3 pct)          (+32.2 pct)                  
  Recurring          2.92                2.88          loss 2.60  
                 (+1.4 pct)          (+6.0 pct)                   
  Net                4.52                4.11            12.30    
                 (+10.1 pct)         (+25.8 pct)      (+2.8 pct)  
  EPS            107.88 yen           92.89 yen       297.07 yen  
  Ann Div                            100.00 yen       120.00 yen  
  -Q2 div                             45.00 yen        60.00 yen  
  -Q4 div                             55.00 yen        60.00 yen  
  
  NOTE - Kissei Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T